ATE501760T1 - E5564 zur verwendung in der behandlung von allograft-abstossung oder host-versus-graft- erkrankungen - Google Patents

E5564 zur verwendung in der behandlung von allograft-abstossung oder host-versus-graft- erkrankungen

Info

Publication number
ATE501760T1
ATE501760T1 AT07019438T AT07019438T ATE501760T1 AT E501760 T1 ATE501760 T1 AT E501760T1 AT 07019438 T AT07019438 T AT 07019438T AT 07019438 T AT07019438 T AT 07019438T AT E501760 T1 ATE501760 T1 AT E501760T1
Authority
AT
Austria
Prior art keywords
versus
host
treatment
allograft rejection
graft diseases
Prior art date
Application number
AT07019438T
Other languages
English (en)
Inventor
Daniel P Rossignol
Melvyn Lynn
William D Kerns
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Application granted granted Critical
Publication of ATE501760T1 publication Critical patent/ATE501760T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
AT07019438T 1999-01-14 2000-01-14 E5564 zur verwendung in der behandlung von allograft-abstossung oder host-versus-graft- erkrankungen ATE501760T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11620299P 1999-01-14 1999-01-14

Publications (1)

Publication Number Publication Date
ATE501760T1 true ATE501760T1 (de) 2011-04-15

Family

ID=22365882

Family Applications (2)

Application Number Title Priority Date Filing Date
AT07019438T ATE501760T1 (de) 1999-01-14 2000-01-14 E5564 zur verwendung in der behandlung von allograft-abstossung oder host-versus-graft- erkrankungen
AT00904375T ATE375798T1 (de) 1999-01-14 2000-01-14 Verwendung von e5564 zur behandlung von sepsis durch intravenöse infusion

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT00904375T ATE375798T1 (de) 1999-01-14 2000-01-14 Verwendung von e5564 zur behandlung von sepsis durch intravenöse infusion

Country Status (11)

Country Link
EP (3) EP2298326A3 (de)
JP (1) JP2002534471A (de)
AT (2) ATE501760T1 (de)
AU (1) AU2614400A (de)
CA (1) CA2359478A1 (de)
CY (1) CY1108039T1 (de)
DE (2) DE60045750D1 (de)
DK (1) DK1158990T3 (de)
ES (1) ES2291188T3 (de)
PT (1) PT1158990E (de)
WO (1) WO2000041703A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1363642A4 (de) * 2000-06-09 2005-02-02 Eisai Co Ltd Verabreichung eines antitoxinmedikamentes durch bolusgabe oder intermittierende intravenöse infusion
US20030105033A1 (en) 2000-06-09 2003-06-05 Rossignol Daniel P. Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion
US7727974B2 (en) 2001-08-10 2010-06-01 Eisai R & D Management Co., Ltd. Methods of reducing the severity of mucositis
WO2003013440A2 (en) * 2001-08-10 2003-02-20 Eisai Co., Ltd. Treatment and prevention of heat shock protein-associated diseases and conditions
WO2016094899A2 (en) 2014-12-12 2016-06-16 The Feinstein Institute For Medical Research Treatment of hmgb1-mediated inflammation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530113A (en) 1991-10-11 1996-06-25 Eisai Co., Ltd. Anti-endotoxin compounds
US5681824A (en) * 1995-06-05 1997-10-28 Eisai Co., Ltd. Substituted liposaccharides useful in the treatment and prevention of endotoxemia

Also Published As

Publication number Publication date
ES2291188T3 (es) 2008-03-01
EP2298326A3 (de) 2011-04-27
EP1158990A1 (de) 2001-12-05
JP2002534471A (ja) 2002-10-15
EP1158990A4 (de) 2003-08-13
EP2298326A2 (de) 2011-03-23
DK1158990T3 (da) 2008-01-28
CY1108039T1 (el) 2013-09-04
PT1158990E (pt) 2007-12-21
ATE375798T1 (de) 2007-11-15
EP1867336B1 (de) 2011-03-16
EP1158990B1 (de) 2007-10-17
DE60036790D1 (de) 2007-11-29
WO2000041703A1 (en) 2000-07-20
EP1867336A3 (de) 2008-04-23
CA2359478A1 (en) 2000-07-20
DE60036790T2 (de) 2008-07-24
EP1867336A2 (de) 2007-12-19
AU2614400A (en) 2000-08-01
DE60045750D1 (de) 2011-04-28

Similar Documents

Publication Publication Date Title
ATE246197T1 (de) Neue heteroaromatische fructose 1,6- bisphosphatase inhibitoren
ES2099158T3 (es) Tratamiento del rechazo de trasplantes o de enfermedades autoinmunitarias y complejo de la formula general x-pro-y-boropro asociada al mismo.
DE69435243D1 (de) Verwendung vom neurotoxischem Komponent von Botulinum Toxin zur Behandlung von Glattmuskelkrankheiten
DE60031396D1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
FR12C0004I1 (de)
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
EA200501891A1 (ru) Гуманизированные антитела, распознающие бета-амилоидный пептид
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
DE69924870D1 (de) Peptidvektoren von stoffen die durch die blut-hirn-scranke dringen
DE69100282T2 (de) Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
DE69129460T2 (de) Verwendung von Anti-ICAM Antikörpern zur Herstellung eines Präparats für die BEHANDLUNG VON ENDOTOXINSCHOCK
ATE196083T1 (de) Verwendung von ferrioxamin-b zur behandlung septischen schocks
ATE356995T1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
DE69912670D1 (de) Substituierte tricyclische Verbindungen und deren Verwendung zur Behandlung von sPLA2-bedingten Erkrankungen
ATE501760T1 (de) E5564 zur verwendung in der behandlung von allograft-abstossung oder host-versus-graft- erkrankungen
ATE312104T1 (de) Verbindungen zur behandlung von beeinträchtigten fundischen entspannung
ATE209914T1 (de) Verwendung von pyridylmethylsulfinyl-1h- benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen
EA199800821A1 (ru) Способ лечения аутизма
ATE130304T1 (de) Neue alpha-glukosidaseinhibitoren.
ATE225181T1 (de) Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen
EA199800822A1 (ru) Способ лечения избыточной агрессии
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
ATE165508T1 (de) Verwendung von 2-methylamino-2-phenylcyclohexanon zur behandlung von infektionen und zur immunmodulation
DE69103294T2 (de) Verwendung der 3-Oxygermylpropionsäure zur Behandlung und Prävention von Diabetes verursacht durch Autoimmunkrankheiten.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties